Dyadic International, Inc common stock (DYAI) Issues Earnings Results

Dyadic International, Inc common stock (OTCMKTS:DYAI) issued its earnings results on Thursday. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The company had revenue of $0.16 million during the quarter.

Dyadic International, Inc common stock remained flat at $$1.47 during midday trading on Friday, MarketBeat Ratings reports. The company had a trading volume of 13,150 shares, compared to its average volume of 7,356. Dyadic International, Inc common stock has a one year low of $1.30 and a one year high of $1.63.

About Dyadic International, Inc common stock

Dyadic International, Inc, a biotechnology company, engages in the discovery, development, production, and sale of enzymes and other proteins in the United States and the Netherlands. It utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial production of human and animal vaccines, monoclonal antibodies, biosimilars and/or biobetters, and other therapeutic proteins.

Recommended Story: What is a closed-end mutual fund (CEF)?

Earnings History for Dyadic International, Inc common stock (OTCMKTS:DYAI)

Receive News & Ratings for Dyadic International Inc common stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyadic International Inc common stock and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply